Long COVID and recovery from Long COVID: quality of life impairments and subjective cognitive decline at a median of 2 years after initial infection.

Publication date: Nov 05, 2024

Recovery from SARS CoV-2 infection is expected within 3 months. Long COVID occurs after SARS-CoV-2 when symptoms are present for more than 3 months that are continuous, relapsing and remitting, or progressive. Better understanding of Long COVID illness trajectories could strengthen patient care and support. We characterized functional impairments, quality of life (QoL), and cognition among patients who recovered from SARS-CoV-2 infection within 3 months (without Long COVID), after 3 months (Recovered Long COVID), or remained symptomatic (Long COVID). Among 7305 patients identified with previous SARS-CoV-2 infection between March 2020 and December 2021, confirmed in the medical record with laboratory test or physician diagnosis, 435 (6%) completed a single self-administered survey between March 2022 and September 2022. Multi-domain QoL and cognitive concerns were evaluated using PROMIS-29 and the Cognitive Change Index-12. Nearly half the participants (47. 7%) were surveyed more than 2 years from initial infection (median = 23. 3 months; IQR = 18. 6, 26. 7) and 86. 7% were surveyed more than 1 year from infection. A significantly greater proportion of the Long COVID (n = 215) group, (Current and Recovered combined), had moderate-to-severe impairment in all health domains assessed compared to those Without Long COVID (n = 220; all p 

Open Access PDF

Concepts Keywords
December Cognition
Decline Long COVID
Physician Post-acute sequelae
September Post-COVID condition
Quality of life
Recovery
Subjective cognitive decline

Semantics

Type Source Name
disease MESH Long COVID
disease IDO quality
disease MESH cognitive decline
disease MESH infection
drug DRUGBANK Tropicamide
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
disease MESH Infectious Diseases
pathway REACTOME Reproduction
disease MESH depression
drug DRUGBANK Coenzyme M
disease MESH sequelae
drug DRUGBANK Factor IX Complex (Human)
disease MESH myalgic encephalomyelitis
disease MESH chronic condition
disease MESH clinical relevance
drug DRUGBANK Trestolone
drug DRUGBANK Indoleacetic acid
disease MESH anxiety
disease MESH comorbidity
disease IDO symptom
disease MESH sore throat
disease MESH Hypertension
disease IDO acute infection
disease MESH relapse
disease MESH mental illness
disease MESH unemployment
drug DRUGBANK Ilex paraguariensis leaf
drug DRUGBANK Stavudine
drug DRUGBANK Etoperidone
drug DRUGBANK Ibuprofen
disease MESH psychological distress
disease MESH neurologic symptoms
disease MESH syndrome
drug DRUGBANK Ademetionine
disease MESH dementia
disease MESH affective symptoms
disease MESH neuroticism
drug DRUGBANK Guanosine
drug DRUGBANK Methyl isocyanate
disease MESH social stigma

Original Article

(Visited 2 times, 1 visits today)